MD Anderson Cancer Center Selects MedQuist Speech and Natural Language Understanding Platform for Enterprise-level Deployment
September 22 2011 - 8:00AM
MedQuist Holdings Inc. (Nasdaq:MEDH), a leading provider of
integrated clinical documentation solutions for the U.S. healthcare
system, announced today that The University of Texas MD Anderson
Cancer Center of Houston, Texas, has selected the company's
cloud-based Speech Understanding™ and Natural Language
Understanding (NLU) platform from M*Modal to become an integral
part of MD Anderson's proprietary ClinicStation electronic medical
record (EMR) system and RadStation radiology solution.
Through the collaboration between M*Modal technology and MD
Anderson, all physicians throughout the enterprise will efficiently
capture the patient story and transform it into structured and
encoded differentiated information. Integrated with the structured
data captured through the EMR, this new level of information
produces comprehensive and highly contextual intelligence that
contributes to effective clinical decision making and actions in
the complex cases faced by MD Anderson, one of the world's premier
centers devoted exclusively to cancer patient care, research,
education and prevention.
The M*Modal clinical content discovery solutions will be
utilized to facilitate the healthcare organization's extensive
analytical and research workflows. With the company's cloud-based
natural language understanding platform, users can search and
interrogate massive volumes of unstructured and structured data to
uncover content-rich information that can be used for a wide
variety of critical clinical and administrative needs.
"While capturing meaningful information from our narrative
documents is a critical part of our EMR strategy, it also enhances
our overall clinical informatics and research environment, to which
we are highly committed," said Lynn Vogel, CIO of MD Anderson.
"After a comprehensive and highly competitive selection process, we
ultimately viewed M*Modal as the optimal partner for realizing our
vision."
Compared with first generation speech recognition technologies,
M*Modal's Speech Understanding natively combines advanced speech
and language understanding. The approach leads to superior speech
recognition results while automatically turning the narrative into
structured and encoded information -- not simply tagged data
elements but also highly meaningful information that drives medical
decision making and action. The company's natural language
understanding supports robust clinical content services that permit
search and discovery across massive amounts of narrative and
structured information.
"With the integration of M*Modal's unique open platform, we will
be able to satisfy two key objectives," added Chuck Suitor,
Director, EMR Development and Support, MD Anderson. "First, we
can accommodate the varied documentation styles and needs of our
caregivers for maximum efficiency. Secondly, we can obtain the
critical intelligence we need to promote the care standard for
which we are recognized, regardless of the method of documentation
of physicians."
"We are pleased to be selected as a strategic partner with such
an acknowledged leader in clinical informatics as MD Anderson,"
noted Vern Davenport, Chairman and CEO of MedQuist Holdings. "We
share a joint vision with MD Anderson of leveraging the narrative
and unstructured patient information to provide deep insight into
clinical information. In turn, this differentiated information will
enhance care delivery and provide complete views of the patient
story contained in ClinicStation and RadStation."
About The University of Texas MD
Anderson Cancer Center
The University of Texas MD Anderson Cancer Center in Houston
ranks as one of the world's most respected centers focused on
cancer patient care, research, education and prevention. MD
Anderson is one of only 40 comprehensive cancer centers designated
by the National Cancer Institute. For eight of the past 10 years,
including 2011, MD Anderson has ranked No. 1 in cancer care in
"America's Best Hospitals," a survey published annually in U.S.
News & World Report.
About MedQuist
MedQuist is a leading provider of clinical narrative capture
services, Speech Understanding technology from M*Modal and clinical
documentation workflow. MedQuist's enterprise solutions – including
mobile voice capture devices, speech recognition, Web-based
workflow platforms and global network of medical editors – help
healthcare facilities facilitate adoption of electronic health
records (EHR), improve patient care, increase physician
satisfaction and lower operational costs. For more information,
please visit www.medquist.com.
The MedQuist Holdings Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=10083
"Safe Harbor" Statement under the U.S. Private Securities
Litigation Reform Act of 1995: Statements in this press release
regarding MedQuist's business that are not historical facts are
"forward-looking statements" that involve risks and uncertainties.
Actual outcomes and results may differ materially from what is
expressed or forecasted in forward-looking statements. As a result,
forward-looking statements speak only as of the date they were
made, and the Company undertakes no obligation to publicly update
or revise any forward-looking statements, whether as a result of
new information, future events or otherwise.
CONTACT: Thomas Mitchell
Director of Marketing
615-798-6630
tmitchell@medquist.com
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jun 2024 to Jul 2024
Medx (CE) (USOTC:MEDH)
Historical Stock Chart
From Jul 2023 to Jul 2024